Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danazol for Cytopenias in Cirrhosis
NCT04873102Phase 2Recruiting
- Sponsor
- University of Southern California
- Start
- Aug 2024
- Primary completion
- Aug 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of danazol in cytopenia, sponsored by University of Southern California. Started Aug 2024; status: recruiting.
02
Drugs
danazol
03
Conditions
cytopenia
Beyond the preview
Go deeper on NCT04873102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04873102.